Global Actinic Keratosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022

  • ID: 3952456
  • Report
  • Region: Global
  • Acute Market Reports
1 of 6
The Actinic Keratosis Market Was Estimated at USD 6,561.8 Mn in 2015 and Is Required to Achieve USD 8,909.7 Mn by 2022

FEATURED COMPANIES

  • Apotex, Inc.
  • Aqua Pharmaceuticals, Llc
  • Galderma S.A.
  • Perrigo Company Plc,
  • MORE

Actinic keratosis (AK) is portrayed by skin papules, macules or plaques coming about because of delayed presentation to hurtful UV introduction and can bring about squamous cell carcinoma. Danger of creating actinic keratosis increments with propelling age and is especially higher in men as against ladies. Around 5-20% of patients with actinic keratosis injuries create dangerous and conceivably deadly squamous cell carcinomas.

Among the different treatment strategies accessible, ruinous treatments, for example, fluid nitrogen cryotherapy and surgical treatment constitute the highest quality level for AK treatment. In 2015, cryotherapy was the most ordinarily looked for treatment by clinicians. Notwithstanding, better clinical consequences of photodynamic treatment and developing inclination for medications in view of medication gadget mix have asked both parental figures and patients to choose novel treatment techniques that offer both propelled adequacy, stylish advantages and decreased danger of future malignancies.

Topical treatment is a delayed treatment and nearly more compelling than different medications yet tolerant consistence is the key issue that ruins the development of this fragment. Photodynamic treatment is the quickest developing treatment all through the gauge time frame because of rising interest for non-obtrusive surgeries, and less treatment sessions are the key variables anticipated that would help this market

North America is the biggest market for actinic keratosis treatment because of developing predominance of AK, better open mindfulness about event of AK and related danger of squamous cell carcinoma. As per American Academy of Dermatology (AAD), around 60% of the Americans matured 40 year or above, Actinic Keratosis is inclined to create having no less than 1 AK injury. Actinic keratosis is antecedents of squamous cell disease. U.S. held the biggest partake in the actinic keratosis market in 2015 attributable to current commonness of actinic keratosis in the region.

Asia Pacific is the quickest developing market for AK medicines. Australia has the most astounding pervasiveness of actinic keratosis going between 40% to 60% in grown-up populace. Developing mindfulness in the area and fast improvement in social insurance framework and human services use are the key development figures Asia Pacific actinic keratosis market.

This market is significantly determined by wide nearness of bland medications and is modestly aggressive. Photodynamic treatment market has built up a specialty with methyl aminolevulinate and aminolevulinic corrosive medications. Galderma and DUSA pharmaceuticals are the main players in this space. A portion of the real players in the worldwide actinic keratosis market are Tolmar Pharmaceuticals, Inc, DUSA Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Aqua Pharmaceuticals, LLC, Galderma SA, Perrigo Company plc, LEO Laboratories, Apotex and others.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Apotex, Inc.
  • Aqua Pharmaceuticals, Llc
  • Galderma S.A.
  • Perrigo Company Plc,
  • MORE

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose Of The Report
1.1.2 Target Audience
1.1.3 Usp And Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase Ii – Primary Research
1.3.3 Phase Iii – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Actinic Keratosis Market Revenue, By Treatment, 2015, (Us$ Mn)
2.2 Global Actinic Keratosis Market Revenue, By Geography, 2015, (USD Million)

Chapter 3 Market Overview
3.1 Introduction And Market Definition
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 High Prevalence Of Actinic Keratosis And Subsequent Risk Of Developing Malignancies
3.3.2 Restraints
3.3.2.1 Non-Adherence To Treatments
3.3.3 Market Opportunities
3.3.3.1 Lucrative Future For Light-Based Treatments
3.4 Attractive Investment Proposition
3.5 Market Competition Assessment Key Players: Global Actinic Keratosis Market

Chapter 4 Global Actinic Keratosis Market, By Treatments
4.1 Preface
4.2 Destructive Treatment
4.2.1 Liquid Nitrogen Cryotherapy
4.2.2 Surgical Therapy
4.3 Photodynamic Therapy
4.3.1 5-Aminolevulinic Acid (Ala)
4.3.2 Methyl Aminolevulinate (Mal)
4.4 Topical Medications
4.4.1 5-Fluorouracil [5-Fu]
4.4.2 Imiquimod
4.4.3 Ingenol Mebutate
4.4.4 Diclofenac Sodium
4.5 Chemical Peels And Dermabrasion

Chapter 5 Global Actinic Keratosis Market, By Geography
5.1 Preface
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Middle East And Africa

Chapter 6 Company Profiles
6.1 Tolmar Pharmaceuticals, Inc.
6.1.1 Tolmar Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.2 Dusa Pharmaceuticals, Inc. (Sun Pharma)
6.2.1 Dusa Pharmaceuticals, Inc. (Sun Pharma): Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.3 Valeant Pharmaceuticals International, Inc.
6.3.1 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.4 Aqua Pharmaceuticals, Llc
6.4.1 Aqua Pharmaceuticals, Llc: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.5 Galderma S.A.
6.5.1 Galderma S.A.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.6 Perrigo Company Plc,
6.6.1 Perrigo Company Plc,: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.7 Apotex, Inc.
6.7.1 Apotex, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
6.8 Leo Laboratories Ltd. (Leo Pharma A/S)
6.8.1 Leo Laboratories Ltd. (Leo Pharma A/S): Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)

Fig. 1 Actinic Keratosis Treatment Market: Research Methodology
Fig. 2 Global Actinic Keratosis Market Revenue, By Treatment, 2015 (USD Mn)
Fig. 3 Global Actinic Keratosis Market Revenue, By Geography, 2015 (Value %)
Fig. 4 Risk Factors Associated With Development Of Actinic Keratosis
Fig. 5 Attractive Investment Proposition: Global Actinic Keratosis Market
Fig. 6 Top 3 Countries: Global Destructive Treatment Market For Actinic Keratosis Treatment, 2014 To 2022 (USD Mn)
Fig. 7 Liquid Nitrogen Cryotherapy Market, 2014 – 2022 (Us$ Mn)
Fig. 8 Surgical Therapies Market, 2014 – 2022 (Us$ Mn)
Fig. 9 Top 3 Countries: Global Photodynamic Therapy Market For Actinic Keratosis Treatment, 2014 To 2022 (USD Mn)
Fig. 10 5-Aminolevulinic Acid (Ala) Market, 2014 – 2022 (Us$ Mn)
Fig. 11 Methyl Aminolevulinate (Mal)Market, 2014 – 2022 (Us$ Mn)
Fig. 12 Top 3 Countries: Global Topical Medications Market For Actinic Keratosis Treatment, 2014 To 2022 (USD Mn)
Fig. 13 5-Fluorouracil (5-Fu) Market, 2014 – 2022 (Us$ Mn)
Fig. 14 Imiquimod Market, 2014 – 2022 (Us$ Mn)
Fig. 15 Ingenol Mebutate Market, 2014 – 2022 (Us$ Mn)
Fig. 16 Diclofenac Sodium Market, 2014 – 2022 (Us$ Mn)
Fig. 17 Chemical Peels And Dermabrasion Market, 2014 – 2022 (Us$ Mn)
Fig. 18 Top 3 Countries: Global Chemical Peels & Dermabrasion Market For Actinic Keratosis Treatment, 2014 To 2022 (USD Mn)

Table 1 Global Actinic Keratosis Market, By Treatment, 2013-2022 (USD Million)
Table 2 Global Destructive Treatment Market, By Type, 2014-2022 (USD Million)
Table 3 Global Photodynamic Therapy Market, By Products, 2014-2022 (USD Million)
Table 4 Global Topical Medications Market, By Products, 2014-2022 (USD Million)
Table 5 Global Actinic Keratosis Market, By Geography, 2014-2022 (USD Million)
Table 6 North America Actinic Keratosis Market, By Geography, 2014-2022 (USD Million)
Table 7 U.S. Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 8 U.S. Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 9 Canada Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 10 Canada Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 11 Europe Actinic Keratosis Market, By Geography, 2014-2022 (USD Million)
Table 12 U.K. Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 13 U.K. Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 14 Germany Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 15 Germany Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 16 France Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 17 France Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 18 Spain Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 19 Spain Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 20 Italy Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 21 Italy Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 22 Rest Of Europe Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 23 Rest Of Europe Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 24 Asia Pacific Actinic Keratosis Market, By Geography, 2014-2022 (USD Million)
Table 25 Japan Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 26 Japan Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 27 China Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 28 China Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 29 Australia Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 30 Australia Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 31 Rest Of Apac Actinic Keratosis Market, By Treatment, 2014-2022 (USD Million)
Table 32 Rest Of Apac Photodynamic Therapy Market, By Type, 2014-2022 (USD Million)
Table 33 Latin America Actinic Keratosis Market, By Treatment, 2015 – 2022 (USD Mn)
Table 34 Latin America Photodynamic Therapy Market, By Type, 2015 – 2022 (USD Mn)
Table 35 Middle East And Africa Actinic Keratosis Market, By Treatment, 2015 – 2022 (USD Mn)
Table 36 Middle East And Africa Photodynamic Therapy Market, By Type, 2015 – 2022 (USD Mn)
Table 37 Tolmar Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 38 Dusa Pharmaceuticals, Inc. (Sun Pharma): Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 39 Valeant Pharmaceuticals International, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 40 Aqua Pharmaceuticals,Llc: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 41 Galderma S.A.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 42 Perrigo Company Plc,: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 43 Apotex, Inc.: Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)
Table 44 Leo Laboratories Ltd. (Leo Pharma A/S): Company Snapshot (Business Description; Financial Health And Budget Allocation; Product Position/Portfolio; News Coverage)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

Apotex, Inc.
Aqua Pharmaceuticals, Llc
Dusa Pharmaceuticals, Inc. (Sun Pharma)
Galderma S.A.
Leo Laboratories Ltd. (Leo Pharma A/S)
Perrigo Company Plc,
Tolmar Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc.

Note: Product cover images may vary from those shown
5 of 6
The methodology is available for download below.
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll